CG Oncology Analyst Ratings
Analysts Are Bullish on Top NA Stocks: Viking Holdings Ltd (VIK), CG Oncology, Inc. (CGON)
CG Oncology Analyst Ratings
Goldman Sachs Upgrades CG Oncology to Buy From Neutral With $50 Price Target
CG Oncology Analyst Ratings
CG Oncology Analyst Ratings
CG Oncology Analyst Ratings
CG Oncology's Cretostimogene Shows Promising Efficacy and Safety in NMIBC Treatment, Merits Buy Rating
Buy Rating Justified by CG Oncology's Cretosmogene Efficacy and Market Positioning
CG Oncology Analyst Ratings
Buy Rating Affirmed for CG Oncology Amidst Bladder Cancer Treatment Landscape and BCG Shortage
Buy Rating Affirmed for CG Oncology on Strong Clinical Data and Market Potential
CG Oncology Analyst Ratings
Buy Rating Justified by CG Oncology's Strong Clinical Trial Results and Promising Cretosimogene Therapy
Buy Rating Affirmed for CG Oncology, Inc. on Promising CG0070 Phase 3 Trials and Unmet Medical Need
CG Oncology's CG0070: A Buy Rating on Breakthrough Bladder Cancer Treatment
CG Oncology Analyst Ratings
Buy Rating Affirmed for CG Oncology on Cretostimogene's Clinical Success and Market Potential
CG Oncology Analyst Ratings